Clinical Trial Details
EORTC-30883
Back to Clinical Trials Database
Phase II study of high dose epirubicin in patients with progressive measurable metastatic non seminomatous germ cell tumours, including extragonadal tumours. (Jointly with the EORTC Early Clinical trials Cooperative Group - Protocol 16881)
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 01-Nov-1988 Date Step1 close: 19-Sep-1990 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 23 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |